Medicine Name: Exforge Hct Tablets 5/160/12.5mg
π Exforge HCT Tablets β Product Specification Sheet
________________________________________
π Requires Prescription
Yes
________________________________________
π Generic Composition
Valsartan + Amlodipine + Hydrochlorothiazide
________________________________________
π©Ί Used For
Treatment of Essential Hypertension
Particularly in patients whose blood pressure is not adequately controlled on dual therapy.
________________________________________
βοΈ How It Works
β’ Β Β Valsartan: An angiotensin II receptor blocker (ARB) that inhibits vasoconstriction and aldosterone effects, lowering blood pressure.
β’ Β Β Amlodipine: A calcium channel blocker (dihydropyridine) that relaxes vascular smooth muscle by inhibiting calcium influx.
β’ Β Β Hydrochlorothiazide (HCT): A thiazide diuretic that increases sodium and chloride excretion, reducing plasma volume and contributing to lower blood pressure.
________________________________________
π‘ Indication
β’ Β Β Indicated for the treatment of essential hypertension in adults, especially those requiring triple therapy for adequate blood pressure control.
________________________________________
π« When Not to Use
β’ Β Β Hypersensitivity to valsartan, amlodipine, hydrochlorothiazide, sulfonamide, or dihydropyridine derivatives
β’ Β Β Pregnancy (2nd and 3rd trimesters)
β’ Β Β Severe hepatic impairment, biliary cirrhosis, or cholestasis
________________________________________
β οΈ Warnings
1. Β Β Fetal Risk: Use of RAS inhibitors (e.g. valsartan) in later pregnancy stages can cause fetal renal dysfunction, oligohydramnios, and skeletal abnormalities.
2. Β Β Symptomatic Hypotension: May occur in salt-/volume-depleted patients; initiate treatment with caution under supervision.
3. Β Β Renal Function Risk: All three components (especially valsartan and HCT) may alter renal function, leading to acute renal failure in susceptible individuals.
________________________________________
π§ͺ Precautions
β’ Β Β Use cautiously in patients with:
o Β Β Unilateral/bilateral renal artery stenosis
o Β Β Stenosis to a solitary kidney
β’ Β Β Monitor renal function (urea, creatinine) and electrolyte balance during therapy.
________________________________________
β Side Effects
β’ Β Β Hematologic: Agranulocytosis, bone marrow failure, leukopenia, neutropenia, thrombocytopenia, aplastic anemia
β’ Β Β Metabolic: Hypokalemia, hyperuricemia, hyperlipidemia, hyperglycemia, hypercalcemia, hypomagnesemia
β’ Β Β Neurological: Headache, hypertonia, visual disturbance
β’ Β Β Cardiovascular: Bradycardia, ventricular tachycardia, atrial fibrillation, arrhythmias
β’ Β Β Others: Anorexia, hypochloremic alkalosis
________________________________________
π Drug Interactions
β’ Β Β Amlodipine: Interacts with CYP3A4 inhibitors (e.g. ketoconazole, clarithromycin), inducers (e.g. rifampicin, St. Johnβs Wort), grapefruit, simvastatin, dantrolene, sildenafil
β’ Β Β Valsartan: Caution with potassium-sparing diuretics, NSAIDs, lithium, cyclosporine, ritonavir
β’ Β Β Hydrochlorothiazide: May interact with metformin, carbamazepine, beta-blockers, digitalis glycosides, methyldopa, lithium, alcohol, contrast agents, and cytotoxic drugs
________________________________________
π§΄ Storage
Yes
Store at room temperature, away from direct light, heat, and moisture.
________________________________________
π€° Pregnancy Category
β οΈ Not recommended during pregnancy
Consult your physician before use, especially during 2nd or 3rd trimester.